{"filing":{"accession_number":"0001213900-26-074953","cik":"0001560293","ticker":"TNONW","company_name":"Tenon Medical, Inc.","form":"8-K","filing_date":"2026-07-02","report_date":null,"primary_document":"ea0296780-8k_tenon.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026074953/ea0296780-8k_tenon.htm"},"events":[{"id":15813,"run_id":14106,"accession_number":"0001213900-26-074953","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.94,"summary":"Tenon Medical completed a registered public offering on July 1, 2026, issuing 11,052,631 shares of common stock (or pre-funded warrants) and 13,263,159 common stock purchase warrants, raising $4.2 million in gross proceeds. The offering includes warrants exercisable at $0.38 and $0.001 per share, with proceeds to be used in part for repayment of convertible notes, reflecting significant dilution to existing shareholders.","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-07-02","form":"8-K","submitted_at":null,"items":[{"id":13711,"accession_number":"0001213900-26-074953","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Tenon Medical completed a public offering on July 1, 2026, issuing 11,052,631 shares of common stock (or pre-funded warrants in lieu thereof) plus common stock purchase warrants to purchase 13,263,159 additional shares, raising $4.2 million in gross proceeds. This is a registered public offering of equity securities with significant dilutive potential—the warrant exercise prices ($0.38 and $0.001) are at or near the offering price, and the warrant shares could substantially increase outstanding shares. The filing explicitly discloses the securities purchase agreements and placement agency agreement under Item 1.01, and the press releases confirm the offering closed. While technically registered (via Form S-1), the dilutive impact and capital-raising nature align with the dilutive_issuance category.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T20:07:15.317071+00:00","company_name":"","ticker":null,"filing_date":""},{"id":13712,"accession_number":"0001213900-26-074953","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Tenon Medical announced the pricing and closing of a $4.2 million public offering of 11,052,631 shares of common stock (or pre-funded warrants) together with 13,263,159 common stock purchase warrants at $0.38 per share. This is a registered public offering of equity securities with significant dilution to existing shareholders. The offering includes pre-funded warrants exercisable at $0.001 per share, which is characteristic of a dilutive capital raise by a small-cap company. The company explicitly states use of proceeds includes \"partial repayment of outstanding convertible notes,\" indicating financial stress and reliance on equity dilution to raise capital.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T20:07:15.317071+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":13711,"accession_number":"0001213900-26-074953","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"Tenon Medical completed a public offering on July 1, 2026, issuing 11,052,631 shares of common stock (or pre-funded warrants in lieu thereof) plus common stock purchase warrants to purchase 13,263,159 additional shares, raising $4.2 million in gross proceeds. This is a registered public offering of equity securities with significant dilutive potential—the warrant exercise prices ($0.38 and $0.001) are at or near the offering price, and the warrant shares could substantially increase outstanding shares. The filing explicitly discloses the securities purchase agreements and placement agency agreement under Item 1.01, and the press releases confirm the offering closed. While technically registered (via Form S-1), the dilutive impact and capital-raising nature align with the dilutive_issuance category.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T20:07:15.317071+00:00","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-07-02"},{"id":13712,"accession_number":"0001213900-26-074953","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Tenon Medical announced the pricing and closing of a $4.2 million public offering of 11,052,631 shares of common stock (or pre-funded warrants) together with 13,263,159 common stock purchase warrants at $0.38 per share. This is a registered public offering of equity securities with significant dilution to existing shareholders. The offering includes pre-funded warrants exercisable at $0.001 per share, which is characteristic of a dilutive capital raise by a small-cap company. The company explicitly states use of proceeds includes \"partial repayment of outstanding convertible notes,\" indicating financial stress and reliance on equity dilution to raise capital.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-02T20:07:15.317071+00:00","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-07-02"}]}